Keep Me Logged In
Justin Gover, GW Pharmaceuticals CEO, speaks with CNBC's Meg Tirrell, about the status of regulatory filings for the Dravet syndrome drug Epidiolex and the coming launch for the medication in U.S. as well as Europe.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by